Successful Integration of Clinical Pharmacists in an OPAT Program: A Real-Life Multidisciplinary Circuit
- PMID: 36009993
- PMCID: PMC9404975
- DOI: 10.3390/antibiotics11081124
Successful Integration of Clinical Pharmacists in an OPAT Program: A Real-Life Multidisciplinary Circuit
Abstract
Outpatient parenteral antimicrobial therapy (OPAT) programs encompass a range of healthcare processes aiming to treat infections at home, with the preferential use of the intravenous route. Although several barriers arise during the implementation of OPAT circuits, recent cumulative data have supported the effectiveness of these programs, demonstrating their application in a safe and cost-effective manner. Given that OPAT is evolving towards treating patients with higher complexity, a multidisciplinary team including physicians, pharmacists, and nursing staff should lead the program. The professionals involved require previous experience in infectious diseases treatment as well as in outpatient healthcare and self-administration. As we describe here, clinical pharmacists exert a key role in OPAT multidisciplinary teams. Their intervention is essential to optimize antimicrobial prescriptions through their participation in stewardship programs as well as to closely follow patients from a pharmacotherapeutic perspective. Moreover, pharmacists provide specialized counseling on antimicrobial treatment technical compounding. In fact, OPAT elaboration in sterile environments and pharmacy department clean rooms increases OPAT stability and safety, enhancing the quality of the program. In summary, building multidisciplinary teams with the involvement of clinical pharmacists improves the management of home-treated infections, promoting a safe self-administration and increasing OPAT patients' quality of life.
Keywords: OPAT; clinical pharmacist; multidisciplinary circuit.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Survey of pharmacists on their roles and perceptions of outpatient parenteral antimicrobial therapy in the United States.Antimicrob Steward Healthc Epidemiol. 2022 Apr 22;2(1):e69. doi: 10.1017/ash.2022.40. eCollection 2022. Antimicrob Steward Healthc Epidemiol. 2022. PMID: 36483442 Free PMC article.
-
Implementing the First Outpatient Parenteral Antimicrobial Therapy (OPAT) Program to Utilize Disposable Elastomeric Pumps in the Gulf Region: Results From a Tertiary Teaching Hospital in the Kingdom of Saudi Arabia.Cureus. 2021 Dec 5;13(12):e20179. doi: 10.7759/cureus.20179. eCollection 2021 Dec. Cureus. 2021. PMID: 34900504 Free PMC article.
-
Best practices, implementation and challenges of outpatient parenteral antimicrobial therapy: results of a worldwide survey among healthcare providers.Ther Adv Infect Dis. 2023 Dec 13;10:20499361231214901. doi: 10.1177/20499361231214901. eCollection 2023 Jan-Dec. Ther Adv Infect Dis. 2023. PMID: 38127471 Free PMC article.
-
Outpatient parenteral antimicrobial therapy and antibiotic stewardship: opponents or teammates?Infection. 2019 Apr;47(2):169-181. doi: 10.1007/s15010-018-1250-1. Epub 2018 Nov 15. Infection. 2019. PMID: 30443780 Review.
-
Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists.J Antimicrob Chemother. 2015 Apr;70(4):965-70. doi: 10.1093/jac/dku517. Epub 2014 Dec 23. J Antimicrob Chemother. 2015. PMID: 25538169 Review.
Cited by
-
Current practices and challenges of outpatient parenteral antimicrobial therapy: a narrative review.J Antimicrob Chemother. 2024 Sep 3;79(9):2083-2102. doi: 10.1093/jac/dkae177. J Antimicrob Chemother. 2024. PMID: 38842523 Free PMC article. Review.
-
A review of antimicrobial stability testing guidance for outpatient parenteral antimicrobial therapy programmes: is it time for global harmonization of testing frameworks?JAC Antimicrob Resist. 2024 Nov 28;6(6):dlae186. doi: 10.1093/jacamr/dlae186. eCollection 2024 Dec. JAC Antimicrob Resist. 2024. PMID: 39619734 Free PMC article. Review.
-
A data-driven financial justification for an outpatient infectious diseases pharmacist.Antimicrob Steward Healthc Epidemiol. 2025 Jul 11;5(1):e155. doi: 10.1017/ash.2025.10051. eCollection 2025. Antimicrob Steward Healthc Epidemiol. 2025. PMID: 40666137 Free PMC article.
-
Taking the route less traveled: on the way to COpAT.Ther Adv Infect Dis. 2023 Aug 15;10:20499361231192771. doi: 10.1177/20499361231192771. eCollection 2023 Jan-Dec. Ther Adv Infect Dis. 2023. PMID: 37600977 Free PMC article. Review.
-
Delivery of Outpatient Parenteral Antimicrobial Therapy (OPAT) in an Ever-Changing National Health Service (UK): Benefits, Barriers, and Opportunities.Antibiotics (Basel). 2025 Apr 29;14(5):451. doi: 10.3390/antibiotics14050451. Antibiotics (Basel). 2025. PMID: 40426518 Free PMC article. Review.
References
-
- Tice A.D., Rehm S.J., Dalovisio J.R., Bradley J.S., Martinelli L.P., Graham D.R., Gainer R.B., Kunkel M.J., Yancey R.W., Williams D.N., et al. Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy. IDSA Guidelines. Clin. Infect. Dis. 2004;38:1651–1672. doi: 10.1086/420939. - DOI - PubMed
-
- Mujal Martínez A., Solá Aznar J., Hernández Ávila M., Aragüás Flores C., Machado Sicilia M.L., Oristrell Salvá J. Safety and Efficacy of Home Intravenous Antibiotic Therapy for Patients Referred by the Hospital Emergency Department. Emergencias. 2013;25:31–36.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials